Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junlin Dong

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|January 31, 2024
The structure and function of olfactory receptorsChenyang Wu, Marc Xu, Junlin Dong, et al.
RSC Advances|February 10, 2023
Molecular basis of ligand selectivity for melatonin receptorsWenqiang Cui, Junlin Dong, Shiyu Wang, et al.
Oncotarget|December 22, 2017
Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapyHanguang Ruan, Junlin Dong, Xueliang Zhou, et al.
STAR Protocols|January 10, 2024
Machine learning for data-driven design of high-safety lithium metal anodeQi Zhang, Junlin Dong, Chuan Zhou, et al.
Journal of Chemical Theory and Computation|February 23, 2024
Machine Learning Deciphered Molecular Mechanistics with Accurate Kinetic and Thermodynamic PredictionJunlin Dong, Shiyu Wang, Wenqiang Cui, et al.
Science and Technology of Advanced Materials|December 3, 2025
Nanocarriers based therapy and diagnosis of brain diseases: cross the blood-brain barrierLijun An, Jinwei Zhang, Xiaobo Wang, et al.
Nature Biotechnology|February 16, 2024
Computational drug development for membrane protein targetsHaijian Li, Xiaolin Sun, Wenqiang Cui, et al.
Frontiers in Pharmacology|August 26, 2024
A review of <i>Phyllanthus urinaria</i> L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinomaLinhua Liu, Bing Wang, Yibo Ma, et al.
Materials Today. Bio|September 23, 2025
Carrier-free nanoparticles based on natural products trigger dual "synergy and attenuation" for enhanced phototherapy of liver cancerXiongqin Wang, Kunhui Sun, Junlin Dong, et al.
ACS Pharmacology & Translational Science|November 15, 2021
Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2Ke Liu, Rongfeng Zou, Wenqiang Cui, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|January 31, 2024
The structure and function of olfactory receptorsChenyang Wu, Marc Xu, Junlin Dong, et al.
RSC Advances|February 10, 2023
Molecular basis of ligand selectivity for melatonin receptorsWenqiang Cui, Junlin Dong, Shiyu Wang, et al.
Oncotarget|December 22, 2017
Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapyHanguang Ruan, Junlin Dong, Xueliang Zhou, et al.
STAR Protocols|January 10, 2024
Machine learning for data-driven design of high-safety lithium metal anodeQi Zhang, Junlin Dong, Chuan Zhou, et al.
Journal of Chemical Theory and Computation|February 23, 2024
Machine Learning Deciphered Molecular Mechanistics with Accurate Kinetic and Thermodynamic PredictionJunlin Dong, Shiyu Wang, Wenqiang Cui, et al.
Science and Technology of Advanced Materials|December 3, 2025
Nanocarriers based therapy and diagnosis of brain diseases: cross the blood-brain barrierLijun An, Jinwei Zhang, Xiaobo Wang, et al.
Nature Biotechnology|February 16, 2024
Computational drug development for membrane protein targetsHaijian Li, Xiaolin Sun, Wenqiang Cui, et al.
Frontiers in Pharmacology|August 26, 2024
A review of <i>Phyllanthus urinaria</i> L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinomaLinhua Liu, Bing Wang, Yibo Ma, et al.
Materials Today. Bio|September 23, 2025
Carrier-free nanoparticles based on natural products trigger dual "synergy and attenuation" for enhanced phototherapy of liver cancerXiongqin Wang, Kunhui Sun, Junlin Dong, et al.
ACS Pharmacology & Translational Science|November 15, 2021
Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2Ke Liu, Rongfeng Zou, Wenqiang Cui, et al.
Pageof 1